Management of Nocturia in the Female

Chang, Andrew C.; Lee, Eugene W.; Lucioni, Alvaro

doi:10.1007/s11934-015-0485-y

Cited by 2 publications

(6 citation statements)

References 67 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nocturia has been found to equally affect men and women [5,6]. However, the pathophysiology of nocturia, and inherently the treatment patterns and outcomes, may differ widely between male and female patients [7,8]. Possibly because nocturia has for a long time been regarded as a prostatic symptom [3,4], the specificities of nocturia in female patients have rarely been studied [7,8].…”

Section: Discussionmentioning

confidence: 99%

“…The prostate can play a significant role in men, whilst gender-specific factors may be involved in women, such as hormonal status and dysfunctions, parity, history of gynaecological surgery, etc. [7,8]. As a result, one may assume that therapeutic patterns and response to treatment may differ according to gender for nocturia.…”

Section: Introductionmentioning

confidence: 99%

“…The possibly slightly higher prevalence of overactive bladder (OAB) in women vs men [9] could also suggest a greater pathophysiological contribution of bladder storage issues likely to influence clinical features and therapeutic management. However, the literature on clinical presentations, treatment and outcomes of nocturia in female patients to confirm this hypothesis is scarce [7,8]. To date, the ICS does not distinguish male and female nocturia [10].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre

Drangsholt

Peyronnet

Arcila-Ruiz

et al. 2019

Arab Journal of Urology

View full text Add to dashboard Cite

Objective : To report the current clinical features, treatment patterns and outcomes of female patients who were seen at a tertiary referral centre with a primary diagnosis of nocturia, and to assess the predictive factors of therapeutic management failure. Patients and methods : A retrospective chart review of all new female patients seen in a single-centre functional urology practice with the diagnosis of nocturia was performed. Up to three visits within a 12-month period from the time of presenting were reviewed. The primary endpoint was patient-reported improvement assessed at each follow-up visit and the change in the number of nocturia episodes. Results : In all, 239 female patients were included for analysis. The prevalence of nocturnal polyuria, reduced bladder capacity, and global polyuria were 75%, 40.2%, and 18.1%, respectively. Within the first two visits, 72.7% of patients had started a treatment beyond behavioural therapies. Anticholinergics were the most commonly initiated treatment (47.2% of patients). At the latest considered visit, 80 patients reported improvement in nocturia (45.5%) and there was a mean – 0.8 decrease in the number of nocturia episodes from 4 to 3.2, which was statistically significant ( P < 0.001). There was no statistically significant association between any of the bladder diary findings and treatment outcomes. A smaller number of nocturia episodes was the only predictive factor of therapeutic management failure in multivariate analysis (odds ratio 0.10; P = 0.01). Conclusions : Whilst the prevalence of nocturnal polyuria in women with nocturia is high, the therapeutic management until 2016 seemed to rely mostly upon overactive bladder medications with a relatively low success rate. Abbreviations : BD: bladder diary; BPS: bladder pain syndrome; ICD(−9)-(10): International Classifications of Disease (ninth revision) (10th revision); NPI: Nocturnal Polyuria Index; OAB: overactive bladder; OR: odd ratio; POP: pelvic organ prolapse

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre

Drangsholt

Peyronnet

Arcila-Ruiz

et al. 2019

Arab Journal of Urology

View full text Add to dashboard Cite

show abstract

“…One symptom in particular, nocturia, seems to be consistently overlooked in clinical practice with regard to its specific aetiology, impact on quality‐of‐life and treatment, despite its high prevalence . The analysis of 43 trials of community‐dwelling people demonstrated that 20.4%–43.9% of women and 11.0%–35.2% of men aged 20–40 years have nocturia ≥1 times per night and 4.4%–18% of women and 2.0%–16.6% of men report about nocturia ≥2 times per night .…”

Section: Background and Objectivesmentioning

confidence: 99%

“…quality-of-life and treatment, despite its high prevalence. 13 The analysis of 43 trials of community-dwelling people demonstrated that 20.4%-43.9% of women and 11.0%-35.2% of men aged 20-40 years have nocturia ≥1 times per night and 4.4%-18% of women and 2.0%- 16.6% of men report about nocturia ≥2 times per night. 14 The prevalence of nocturia rises dramatically with ageing.…”

mentioning

confidence: 99%

Nocturia is often inadequately assessed, diagnosed and treated by physicians: results of an observational, real‐life practice database containing 8659 European and US ‐American patients

et al. 2016

View full text Add to dashboard Cite

SummaryAimsThe aim of this study was to investigate the quality and timing of the diagnosis and treatment of nocturia in real‐life practice in European and US‐American patients to obtain better insights into the management of nocturia in different Western healthcare systems.MethodsData were drawn from the “LUTS Disease Specific Programme,” a real‐life survey of physicians and patients in France, Germany, Spain, UK and the USA. Physicians completed a patient record form for lower urinary tract symptoms (LUTS) patients. Patients filled out a self‐completion form, indicating – among other items – information on the mean number of day‐ and night‐time voids during the last 7 days, and questions on the management of LUTS in daily practice.ResultsIn total, 8659 patients were analysed. The majority of patients initially consulted a physician because of worsening of LUTS frequency (43%–58%) or severity (44%–55%). Only 37% of all LUTS diagnoses, regardless of the appearance or severity of nocturia, were based on bladder diaries. Patients took approximately 1 year to consult a medical professional following the onset of LUTS. At the initial visit, most patients received advice on behavioural strategies. Regardless the type of LUTS and physician, 59% of men received α‐blockers and 76% of women antimuscarinics.ConclusionsData show that patients with nocturia and LUTS accept their symptoms for a considerable period before they seek help or ultimately receive treatment. They may therefore be enduring significant negative impact on their quality‐of‐life which could be avoided. Physicians rarely use bladder diaries and primarily use antimuscarinics (women) or α‐blockers (men). Improved awareness of nocturia among patients and physicians could improve the management of nocturia.

show abstract

Management of Nocturia in the Female

Cited by 2 publications

References 67 publications

Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre

Nocturia in female patients: Current clinical features, treatment patterns and outcomes at a tertiary referral centre

Nocturia is often inadequately assessed, diagnosed and treated by physicians: results of an observational, real‐life practice database containing 8659 European and US ‐American patients

Contact Info

Product

Resources

About